CXCL3 acts on the CXCR2 receptor, whereas CXCL6 acts on both CXCR1 and CXCR2 receptors, ultimately resulting in the recruitment of tumor-associated neutrophils and the promotion of tumor angiogenesis [18]. This evidence concerns the gene CXCL3 and neoplasm.